Petition update

What is known about our other coexisting pandemic

Carl Tuttle
Hudson, NH, United States

Apr 1, 2020 — 

There are nearly 90,000 signatures on this petition calling attention to the “Coexisting Pandemic” that is destroying lives, ending careers while leaving its victim in financial ruin. Our public health officials need to know we are not going away and for that reason I sent the following letter to Dr. Anthony Fauci with Cc: to the Tick Borne Disease Working Group as a reminder that we need to address this antibiotic resistant/tolerant superbug. When this COVID-19 fades away we will still be left with the never-ending threat of Lyme disease.

The letter below was previously posted to the petition on March 31, 2016:

---------- Original Message ----------
Cc: (98 Undisclosed recipients)
Date: March 31, 2020 at 1:19 PM
Subject: "A disease that has spiraled out of control into a 21st century plague"

To the Tick-Borne Disease Working Group,

In light of recent events; I thought it would be timely to review what is known about our other coexisting pandemic which has been deceitfully swept under the rug through suppression of evidence/science because it doesn’t suit the narrative.

2016 Letter to MedPage Today with Cc: to NEJM and the authors of the study Identified below:

From: "Carl Tuttle"
To:, "n walsh"
Cc: "s yurkiewicz" , "m smith" , "s gupta" , "ivan-oransky",, "Anneleen Berende" , "BJ Kullberg"
Sent: Thursday, March 31, 2016 12:19:04 PM
Subject: Long-Term Antibiotics Fail Again in Lyme Disease

Long-Term Antibiotics Fail Again in Lyme Disease

By Nancy Walsh, Senior Staff Writer, MedPage Today

“Lengthy antibiotic treatment failed to improve quality of life among patients with symptoms attributed to persistent Lyme disease, a randomized Dutch study found.”

March 31, 2016

MedPage Today, LLC
345 Hudson Street
16th Floor
New York, NY 10014

In reference to the MedPage article written by Nancy Walsh, I would like to point out the following case studies identifying persistent Borrelia infection after long term antibiotic treatment:

1. Isolation and polymerase chain reaction typing of Borrelia afzelii from a skin lesion in a seronegative patient with generalized ulcerating bullous lichen sclerosus et atrophicus.

Breier F1, Khanakah G, Stanek G, Kunz G, Aberer E, Schmidt B, Tappeiner G
Department of Dermatology, Lainz Municipal Hospital, Wolkersbergenstrasse 1, A-1130 Vienna, Austria.

Persistent Infection

-Spirochaetes were detected by silver staining.

-Serology for B. burgdorferi sensu lato was repeatedly negative.

-Despite treatment with four courses of ceftriaxone with or without methylprednisone for up to 20 days, progression of sclerosus et atrophicus (LSA) was only stopped for a maximum of 1 year.

-After one further 28-day course of ceftriaxone the lesions stopped expanding and sclerosis of the skin was diminished.

Conclusion: “Borrelia [the Lyme disease bacteria] may possibly be able to remain dormant in certain tissue compartments”

2. Granulomatous hepatitis associated with chronic Borrelia burgdorferi infection: a case report


Although Lyme borreliosis has been linked to hepatitis in early stages of infection, the association of chronic Borrelia burgdorferi infection with hepatic disease remains largely unexplored. We present the case of a 53-year-old woman diagnosed with Lyme disease who developed acute hepatitis with elevated liver enzymes while on antibiotic treatment. Histological examination of liver biopsy tissue revealed spirochetes dispersed throughout the hepatic parenchyma, and the spirochetes were identified as Borrelia burgdorferi by molecular testing with specific DNA probes. Motile spirochetes were also isolated from the patient’s blood culture, and the isolate was identified as Borrelia burgdorferi sensu stricto by two independent laboratories using molecular techniques. These findings indicate that the patient had active, systemic Borrelia burgdorferi infection and consequent Lyme hepatitis, despite antibiotic therapy.

3. Standard antibiotic treatment for Lyme disease does not kill persistent Borrelia bacteria.

-What has tuberculosis and Borrelia burgdorferi in common? In the late stage of the disease occurs persistent (tolerant) bacteria, which essentially means that the bacteria lasts and lasts and lasts. They protect themselves against antibiotics and are difficult to treat.

- Both Borrelia burgdorferi and tuberculosis is relatively easy to cure in the early stages, even with the use of one antibiotic. In the late stage it is impossible to cure the disease with the same type of treatment in the acute phase, said Dr. Ying Zhang when he visited the year NorVect conference.

-Dr. Ying Zhang is a professor at the Department of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health

I would like to point out that the scientific community freely describes persistent B. burgdorferi infection in a wide variety of animals (not just reservoir animals) as we have studies proving persistent infection in mice, dogs, ponies, monkeys and cows but for some strange reason there is no persistent/chronic infection in humans. This is a fabricated conviction by the handful of academic researchers who control the narrative as we learned recently of Professor Kim Lewis’ work identifying the presence of persister cells in the bacterium that causes Lyme disease which are drug-tolerant, dormant variants of regular cells.

4. Researchers investigate four promising new treatments for Lyme disease

Prof Lewis: “Doxycycline may be standard first-line treatment for Lyme, but, says Lewis, it doesn’t even kill B. burgdorferi, it just suppresses its growth, leaving the rest of the work to the immune system.”

We have a growing pandemic of late stage chronic Lyme patients who are deliberately ignored. More importantly, our blood supply is not screened for Lyme disease:

5. Distribution and survival of Borrelia miyamotoi in human blood components
Aaron M. Thorp and Laura Tonnetti* Article first published online: 21 DEC 2015;jsessionid=09EB8FF4A3A0A1BB2DA30954B20D08E9.f02t04


“This study demonstrated that B. miyamotoi can survive standard storage conditions of most human blood components, suggesting the possibility of transmission by blood transfusion.”

6. Culture evidence of Lyme disease in antibiotic treated patients living in the Southeast.

A study published in the December 2015 issue of Clinical Microbiology and Infection, which provides culture confirmation of chronic Lyme disease in 24 patients in North Carolina, Florida, and Georgia. All had undergone previous antibiotic treatment.

7. Scotty Shelton and Persistent Infection in Saginaw MN

“Scotty's brain (cerebral cortex) was positive for Borrelia burgdorferi and Borrelia myamotoi, his testicle is positive for Bb. We are now testing other tissues. Seven years of antibiotics and 3.5 years of natural treatments (along with antibiotics) and he was highly highly positive.”

Four decades have past since the discovery of Lyme disease and during this time-frame horribly disabled Lyme patients have been ostracized, bullied, called “Lyme loonies” by Philip Baker, (Past Lyme disease program officer for the NIH), misdiagnosed as psychiatric patients or the latest designation as quoted by Wormser in the MedPage Today article: "medically unexplained symptoms” (MUS)

How much proof is required to acknowledge we are dealing with an antibiotic resistant/tolerant superbug? How many patients in the past four decades have had their lives altered forever by this superbug while the medical community practices willful ignorance? Current antibody tests (Serology) for Lyme disease cannot be used to gauge treatment failure or success preserving this forty year dogma that persistent Lyme disease does not exist. Second generation DNA sequencing is being used to diagnose Borrelia infection in biopsied tissue samples post-mortem so why aren’t we using this technology in the living?

What we have here is collusion to deny a chronic disease; a disease that has spiraled out of control into a 21st century plague. The medical establishment has been led to believe that “chronic Lyme” is a fictitious disease and hundreds of thousands perhaps millions of patients around the globe are left untreated/undertreated and suffering. Foreign health agencies are blindly following what has been deceitfully established here in the United States; a false perception that Lyme disease is a "minor disease"

Lyme Disease: Call for a “Manhattan Project” to Combat the Epidemic
Raphael B. Stricker and Lorraine Johnson

You or a loved one is a tick bite away from experiencing this travesty.

Carl Tuttle
Hudson, NH

Suppressed scientific evidence:
Peer Reviewed Evidence of Persistence of Lyme Disease Spirochete Borrelia burgdorferi and Tick-Borne Diseases after the mandated IDSA treatment guideline.

When “evidence based medicine” has been spun to fit bias agendas and the patient voice has been intentionally ignored who investigates the dishonest science? -Carl Tuttle


Keep fighting for people power!

Politicians and rich CEOs shouldn't make all the decisions. Today we ask you to help keep free and independent. Our job as a public benefit company is to help petitions like this one fight back and get heard. If everyone who saw this chipped in monthly we'd secure's future today. Help us hold the powerful to account. Can you spare a minute to become a member today?

I'll power Change with $5 monthlyPayment method


Please enter a comment.

We were unable to post your comment. Please try again.